Alternative splicing modulates cancer aggressiveness: role in EMT/metastasis and chemoresistance
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alternative splicing modulates cancer aggressiveness: role in EMT/metastasis and chemoresistance
Authors
Keywords
-
Journal
MOLECULAR BIOLOGY REPORTS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-05
DOI
10.1007/s11033-020-06094-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oncogenic functions of the EMT-related transcription factor ZEB1 in breast cancer
- (2020) Hua-Tao Wu et al. Journal of Translational Medicine
- TGF-β1 promotes epithelial-to-mesenchymal transition and stemness of prostate cancer cells by inducing PCBP1 degradation and alternative splicing of CD44
- (2020) Qi Chen et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Phytochemicals modulate cancer aggressiveness: A review depicting the anticancer efficacy of dietary polyphenols and their combinations
- (2020) Tulika Mitra et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Role of Wnt/β-Catenin Signaling in the Chemoresistance Modulation of Colorectal Cancer
- (2020) Shengli Yuan et al. Biomed Research International
- Correlation of PKM2 and CD44 Protein Expression with Poor Prognosis in Platinum-Treated Epithelial Ovarian Cancer: A Retrospective Study
- (2020) Chara Papadaki et al. Cancers
- MYCT1 inhibits the EMT and migration of laryngeal cancer cells via the SP1/miR-629-3p/ESRP2 pathway
- (2020) Peng-Jie Yue et al. CELLULAR SIGNALLING
- The role of CD44 in pathological angiogenesis
- (2020) Li Chen et al. FASEB JOURNAL
- Splicing factor ESRP1 controls ER‐positive breast cancer by altering metabolic pathways
- (2019) Yesim Gökmen‐Polar et al. EMBO REPORTS
- CD44 splice isoform switching determines breast cancer stem cell state
- (2019) Honghong Zhang et al. GENES & DEVELOPMENT
- The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis
- (2019) Zhenpeng Wang et al. Frontiers in Oncology
- Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells
- (2019) Raghupathy Vengoji et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Matrix Hyaluronan-CD44 Interaction Activates MicroRNA and LncRNA Signaling Associated With Chemoresistance, Invasion, and Tumor Progression
- (2019) Lilly Y. W. Bourguignon Frontiers in Oncology
- Dietary-phytochemical mediated reversion of cancer-specific splicing inhibits Warburg effect in head and neck cancer
- (2019) Sandhya Yadav et al. BMC CANCER
- Hyaluronan-CD44 axis orchestrates cancer stem cell functions
- (2019) Spyros S. Skandalis et al. CELLULAR SIGNALLING
- Addiction of mesenchymal phenotypes on the FGF/FGFR axis in oral squamous cell carcinoma cells
- (2019) Asami Hotta Osada et al. PLoS One
- Integrated Analysis of Structural Variation and RNA Expression of FGFR2 and Its Splicing Modulator ESRP1 Highlight the ESRP1amp-FGFR2norm-FGFR2-IIIchigh Axis in Diffuse Gastric Cancer
- (2019) Sara Pinto Teles et al. Cancers
- Splicing Dysregulation as Oncogenic Driver and Passenger Factor in Brain Tumors
- (2019) Pamela Bielli et al. Cells
- Epithelial Splicing Regulatory Protein 1 Inhibits the Invasion and Metastasis of Lung Adenocarcinoma
- (2018) Lingmei Li et al. AMERICAN JOURNAL OF PATHOLOGY
- Aberrant FGFR tyrosine kinase signaling enhances the Warburg effect by reprogramming LDH isoform expression and activity in prostate cancer
- (2018) Junchen Liu et al. CANCER RESEARCH
- FGFR4 Links Glucose Metabolism and Chemotherapy Resistance in Breast Cancer
- (2018) Min Xu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- The role of alternative splicing in cancer drug resistance
- (2018) Zahava Siegfried et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Role of fibroblast growth factor receptor-2 splicing in normal and cancer cells
- (2018) Toshiyuki Ishiwata Frontiers in Bioscience-Landmark
- Stemness and chemoresistance are imparted to the OC cells through TGFβ1 driven EMT
- (2018) Tulika Mitra et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Mesenchymal splice isoform of CD44 (CD44s) promotes EMT/invasion and imparts stem-like properties to ovarian cancer cells
- (2018) Rahul Bhattacharya et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- FGF9-induced ovarian cancer cell invasion involves VEGF-A/VEGFR2 augmentation by virtue of ETS1 upregulation and metabolic reprogramming
- (2018) Rahul Bhattacharya et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The biology and role of CD44 in cancer progression: therapeutic implications
- (2018) Chen Chen et al. Journal of Hematology & Oncology
- CD44 exerts a functional role during EMT induction in cisplatin-resistant head and neck cancer cells
- (2018) Hiroaki Miyazaki et al. Oncotarget
- Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics
- (2018) Laura M. Urbanski et al. Wiley Interdisciplinary Reviews-RNA
- Cancer-associated MORC2 mutant M276I regulates an hnRNPM-mediated CD44 splicing switch to promote invasion and metastasis in triple-negative breast cancer
- (2018) Fang-Lin Zhang et al. CANCER RESEARCH
- Coregulation of alternative splicing by hnRNPM and ESRP1 during EMT
- (2018) Samuel E. Harvey et al. RNA
- Overexpression of CD44 Variant 9: A Novel Cancer Stem Cell Marker in Human Cholangiocarcinoma in Relation to Inflammation
- (2018) Nattawan Suwannakul et al. MEDIATORS OF INFLAMMATION
- The long non-coding RNA MALAT1 promotes ovarian cancer progression by regulating RBFOX2-mediated alternative splicing
- (2018) Michael A. Gordon et al. MOLECULAR CARCINOGENESIS
- Aberrant RNA Splicing in Cancer and Drug Resistance
- (2018) Bi-Dar Wang et al. Cancers
- HnRNPM and CD44s expression affects tumor aggressiveness and predicts poor prognosis in breast cancer with axillary lymph node metastases
- (2017) Huizhi Sun et al. GENES CHROMOSOMES & CANCER
- Therapeutic Applications of Targeted Alternative Splicing to Cancer Treatment
- (2017) Jung-Chun Lin INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance
- (2017) Romana-Rea Begicevic et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Isoform switch of CD44 induces different chemotactic and tumorigenic ability in gallbladder cancer
- (2017) Takeshi Miwa et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The CD44 standard isoform contributes to radioresistance of pancreatic cancer cells
- (2017) Kento Tsubouchi et al. JOURNAL OF RADIATION RESEARCH
- EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression
- (2017) Davide Pradella et al. Molecular Cancer
- The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer
- (2017) Pingting Zhou et al. Molecular Cancer
- FOXC1 Regulates FGFR1 Isoform Switching to Promote Invasion Following TGFβ-Induced EMT
- (2017) Alex Hopkins et al. MOLECULAR CANCER RESEARCH
- Stemness in Cancer: Stem Cells, Cancer Stem Cells, and Their Microenvironment
- (2017) Pedro M. Aponte et al. Stem Cells International
- Human cancer cells with stem cell-like phenotype exhibit enhanced sensitivity to the cytotoxicity of IL-2 and IL-15 activated natural killer cells
- (2016) Tao Yin et al. CELLULAR IMMUNOLOGY
- CD44 Expression Level and Isoform Contributes to Pancreatic Cancer Cell Plasticity, Invasiveness, and Response to Therapy
- (2016) Shujie Zhao et al. CLINICAL CANCER RESEARCH
- CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer
- (2016) Hanxiao Xu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- ZEB1 drives epithelial-to-mesenchymal transition in lung cancer
- (2016) Jill E. Larsen et al. JOURNAL OF CLINICAL INVESTIGATION
- Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancer
- (2016) Pietro Fici et al. Oncotarget
- Role of EMT in Metastasis and Therapy Resistance
- (2016) Bethany Smith et al. Journal of Clinical Medicine
- The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and lapatinib-resistance of esophageal squamous cell carcinoma
- (2015) Shin Saito et al. BMC CANCER
- Genome-wide analysis of alternative transcripts in human breast cancer
- (2015) Ji Wen et al. BREAST CANCER RESEARCH AND TREATMENT
- CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer
- (2015) Francisca Tjhay et al. CANCER SCIENCE
- Pancreatic cancer cells express CD44 variant 9 and multidrug resistance protein 1 during mitosis
- (2015) Shizuka Kiuchi et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells
- (2015) Bogdan-Tiberius Preca et al. INTERNATIONAL JOURNAL OF CANCER
- The Arkadia-ESRP2 axis suppresses tumor progression: analyses in clear-cell renal cell carcinoma
- (2015) A Mizutani et al. ONCOGENE
- Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes
- (2015) A Sveen et al. ONCOGENE
- The p53 Isoform Δ133p53β Promotes Cancer Stem Cell Potential
- (2015) Nikola Arsic et al. Stem Cell Reports
- Perspectives of CD44 targeting therapies
- (2014) V. Orian-Rousseau et al. ARCHIVES OF TOXICOLOGY
- Antibody Against CD44s Inhibits Pancreatic Tumor Initiation and Postradiation Recurrence in Mice
- (2014) Ling Li et al. GASTROENTEROLOGY
- Cell type-restricted activity of hnRNPM promotes breast cancer metastasis via regulating alternative splicing
- (2014) Y. Xu et al. GENES & DEVELOPMENT
- HPV16 E5 expression induces switching from FGFR2b to FGFR2c and epithelial-mesenchymal transition
- (2014) Danilo Ranieri et al. INTERNATIONAL JOURNAL OF CANCER
- Epithelial Splicing Regulatory Proteins 1 (ESRP1) and 2 (ESRP2) Suppress Cancer Cell Motility via Different Mechanisms
- (2014) Hiroki Ishii et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Expression levels of SF3B3 correlate with prognosis and endocrine resistance in estrogen receptor-positive breast cancer
- (2014) Yesim Gökmen-Polar et al. MODERN PATHOLOGY
- Transcriptome-wide Landscape of Pre-mRNA Alternative Splicing Associated with Metastatic Colonization
- (2014) Zhi-xiang Lu et al. MOLECULAR CANCER RESEARCH
- Tumor-Specific Isoform Switch of the Fibroblast Growth Factor Receptor 2 Underlies the Mesenchymal and Malignant Phenotypes of Clear Cell Renal Cell Carcinomas
- (2013) Q. Zhao et al. CLINICAL CANCER RESEARCH
- The RNA-binding protein Rbfox2: an essential regulator of EMT-driven alternative splicing and a mediator of cellular invasion
- (2013) C Braeutigam et al. ONCOGENE
- Epithelial splicing regulatory protein 1 is a favorable prognostic factor in pancreatic cancer that attenuates pancreatic metastases
- (2013) J Ueda et al. ONCOGENE
- N-cadherin/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem/progenitor cell-like properties
- (2013) X Qian et al. ONCOGENE
- Hallmarks of alternative splicing in cancer
- (2013) S Oltean et al. ONCOGENE
- Expression of TP53 Isoforms p53β or p53γ Enhances Chemosensitivity in TP53null Cell Lines
- (2013) Elisabeth Silden et al. PLoS One
- CD44 Staining of Cancer Stem-Like Cells Is Influenced by Down-Regulation of CD44 Variant Isoforms and Up-Regulation of the Standard CD44 Isoform in the Population of Cells That Have Undergone Epithelial-to-Mesenchymal Transition
- (2013) Adrian Biddle et al. PLoS One
- The RNA Binding Protein ESRP1 Fine-Tunes the Expression of Pluripotency-Related Factors in Mouse Embryonic Stem Cells
- (2013) Sharmila Fagoonee et al. PLoS One
- Uncovering the role of p53 splice variants in human malignancy: a clinical perspective
- (2013) Jean-Christophe Bourdon et al. OncoTargets and Therapy
- MBNL1 and RBFOX2 cooperate to establish a splicing programme involved in pluripotent stem cell differentiation
- (2013) Julian P. Venables et al. Nature Communications
- Role of splice variants in the metastatic progression of prostate cancer: Figure 1
- (2012) Rachel M. Hagen et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Modulation of Glucose Metabolism by CD44 Contributes to Antioxidant Status and Drug Resistance in Cancer Cells
- (2012) M. Tamada et al. CANCER RESEARCH
- Targeting the EGFR signaling pathway in cancer therapy
- (2012) Parthasarathy Seshacharyulu et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Snail Represses the Splicing Regulator Epithelial Splicing Regulatory Protein 1 to Promote Epithelial-Mesenchymal Transition
- (2012) Lauren M. Reinke et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- RBFOX2 Is an Important Regulator of Mesenchymal Tissue-Specific Splicing in both Normal and Cancer Tissues
- (2012) J. P. Venables et al. MOLECULAR AND CELLULAR BIOLOGY
- CD44s and CD44v6 in Diagnosis and Prognosis of Human Bladder Cancer
- (2012) Ola M. Omran et al. ULTRASTRUCTURAL PATHOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression
- (2011) Rhonda L. Brown et al. JOURNAL OF CLINICAL INVESTIGATION
- An EMT–Driven Alternative Splicing Program Occurs in Human Breast Cancer and Modulates Cellular Phenotype
- (2011) Irina M. Shapiro et al. PLoS Genetics
- Reduced Expression of Fibroblast Growth Factor Receptor 2IIIb in Hepatocellular Carcinoma Induces a More Aggressive Growth
- (2010) Thomas Amann et al. AMERICAN JOURNAL OF PATHOLOGY
- Fibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration
- (2010) G Sonvilla et al. BRITISH JOURNAL OF CANCER
- Paths of FGFR-driven tumorigenesis
- (2010) Victor D. Acevedo et al. CELL CYCLE
- An ESRP-regulated splicing programme is abrogated during the epithelial–mesenchymal transition
- (2010) Claude C Warzecha et al. EMBO JOURNAL
- ZEB1 in Pancreatic Cancer
- (2010) Ulrich Wellner et al. Cancers
- Metastasis mechanisms
- (2009) Thomas R. Geiger et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Conserved intron positions in FGFR genes reflect the modular structure of FGFR and reveal stepwise addition of domains to an already complex ancestral FGFR
- (2009) Nicole Rebscher et al. DEVELOPMENT GENES AND EVOLUTION
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches
- (2009) Mo Chen et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53-Mediated Apoptosis and Acquiring a Stem-Like Phenotype in Ovarian Cancer Cells
- (2009) Nawneet K. Kurrey et al. STEM CELLS
- A p120 Catenin Isoform Switch Affects Rho Activity, Induces Tumor Cell Invasion, and Predicts Metastatic Disease
- (2008) Masahiro Yanagisawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Alternative isoform regulation in human tissue transcriptomes
- (2008) Eric T. Wang et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started